We focus our efforts on developing and bringing new medicines to the market in neglected indications where the medical need is the most salient: pediatric diseases, particularly severe forms of epilepsy and pediatric oncology conditions, orphan or ultra-orphan diseases. All our development programs are patient-centered and encompass a particular focus on the pharmaceutical formulation to ensure high quality, greater dose flexibility, easier administration, and better acceptance of drugs by the patients.